Introduction
The muscular dystrophies are a collection of degenerative neuromuscular diseases. The most common and devastating form of muscular dystrophyi sD uchenne muscular dystrophy( DMD), which affects 1 in every 3500 male births. DMD is characterised by progressive degeneration of skeletal muscle and an inability,o vert ime, of the muscle to adequately repair itself, so that healthy muscle is gradually replaced by fat and connective tissue. This causes profound muscle weakness, such that affected individuals are often wheelchair-bound by the age of 10-12, and usually die of respiratory and/or cardiac failure by about the age of 20. Despite extensive research into the genetic and cellular mechanisms underlying DMD, currently there are no effective treatments for this disease.
It has been known for overa d ecade that DMD is caused by an X-chromosome gene mutation resulting in the absence of the protein dystrophin in skeletal muscle. 1 Dystrophin is a large protein (427 kD) that links the cytoskeleton to a complexo fp roteins in the surface membrane of muscle fibres, which in turn interact with the extracellular matrix. The mdx mouse, an animal model of DMD, also has a genetic mutation resulting in the loss of dystrophin, although for reasons not entirely understood it has a relatively mild phenotype compared to individuals with DMD. 2 Over the past 15-20 years, the mdx mouse has been widely used to investigate the mechanisms that cause dystrophic muscles to be more vulnerable to damage and degeneration. The mdx mouse also has a key role in testing possible therapeutic interventions, which are aimed at slowing the progression of, or preventing, this disease. Existing studies suggest that multiple factors contribute to muscle damage in dystrophic muscle. The purpose of this reviewistopresent some of the physiological pathways that might be involved in dystrophic muscle disease, with a particular focus on the effects of calcium (Ca 2+ )a nd reactive oxygen species (ROS). A further aim is to try to establish hows ome of these damage pathways might interact, in an effort to provide a broader understanding of the dystrophic pathogenesis.
Intracellular Ca 2+ in dystrophic muscle
Early research 3 showed that the total Ca 2+ measured in muscle biopsies from DMD patients was greater than that from normal muscle. While the general consensus from a number of studies is that the free intracellular Ca 2+ concentration ([Ca 2+ ] i )i sa lso higher in muscle fibres from mdx mice compared to that measured in wild-type fibres, other papers have reported no significant rise in [Ca 2+ ] i (see 4,5 for recent reviews). A possible reason whys ome investigators do not find elevated [Ca 2+ ] i in mdx muscle may be partly due to methodological differences between the various studies, particularly relating to the fluorescent indicators used to measure [Ca 2+ ] i and the previous contractile activity and age of the cells.
6 Also, for a period of time, Ca 2+ entering the fibre can be effectively taken up by the mitochondria and sarcoplasmic reticulum (SR), and it has been shown that the Ca 2+ concentration in the SR is greater in mdx myotubes than in normal myotubes. Furthermore, it has also been reported that the [Ca 2+ ] i in the subsarcolemmal space is about 3 times greater in mdx muscle. 8 Thus, taking all of these observations into account, there is strong evidence to suggest that Ca 2+ homeostasis is disturbed in dystrophic muscles. The next sections will discuss possible physiological pathways of Ca 2+ entry and howC a 2+ might contribute to dystrophic muscle damage.
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2+ entry pathways: Membrane tears or ion channels?
Over the past 15 years or so, twom ain theories have been proposed as to whyt he absence of dystrophin causes muscles to be particularly susceptible to damage and degeneration. 9 (1) Dystrophin may have ani mportant structural role in maintaining the integrity of the muscle fibre membrane during contraction, particularly those involving stretch. Thus, it is suggested that in the absence of dystrophin, stretched contractions lead to membrane tears. 10 (2) Dystrophin may be involved in the aggregation of ion channels in the membrane and its absence may lead to abnormal channel function. 11 According to both hypotheses, there would be a rise in [Ca 2+ ] i ,as ubsequent loss of Ca 2+ homeostasis and the activation of various degradative pathways (discussed below), which lead to muscle fibre necrosis.
Membrane tears
It is well established that dystrophic muscles not only lack dystrophin but also have greatly reduced levels of manyo ther dystrophin-associated membrane glycoproteins. 12 Furthermore, some mdx fibres from older mice have been shown to have abnormal architecture, with fibre splitting and branching. 13 Thus, manyi nv estigators have postulated that these factors render the surface membrane of dystrophic fibres more susceptible to stresses imposed during contractions, particularly those involving stretch. 10, [13] [14] [15] According to this theory,t ransient membrane tears develop, thereby allowing extracellular Ca 2+ to rapidly enter the fibre along its electrochemical gradient. However, although this is a plausible theory,i st here anyd irect experimental evidence to support it?
While there is ample data showing that muscles from mdx mice have increased membrane permeability,asshown by large plasma concentrations of muscle-specific enzymes such as creatine kinase (CK) and greater uptakeo f membrane impermeable dyes into dystrophic muscle fibres, [16] [17] [18] this, in itself, does not support the idea that these movements are due to mechanical tears in the sarcolemma. Unfortunately,t here are only a fews tudies that have attempted to address the issue of the mechanical strength of the dystrophic muscle fibre membrane. While the membrane stiffness of mdx myotubes was found to be about four times less than that of normal myotubes, 19 twoe arlier studies reported little or no difference in the tensile strength of the sarcolemma of muscle fibres from mdx mice compared to wild-type, as assessed by measuring the suction required to burst membrane patches. 11, 20 Thus, it appears that while dystrophin is important for maintaining membrane stiffness, perhaps due to structural connections between the cytoskeleton, membrane and the extracellular matrix, the intrinsic strength of the sarcolemma seems to be ap roperty of the lipid bilayer,w hich is not affected by the absence of dystrophin. 21 
Ion Channels
Since manyi on channels are structurally linked to membrane-bound proteins, it has been hypothesized that the distribution and/or function of such channels might be altered in dystrophic muscle. Of particular interest are those channels that allowC a 2+ entry into muscle fibres. Steinhardt and colleagues have reported the presence of a Ca 2+ leak channel, which has been shown to be more active in mdx muscle, and thus might provide a source of Ca 2+ entry into the fibre. 22 This channel was found to have properties consistent with it being a store-operated channel 6 and interestingly,i ts activity was enhanced by the L-type Ca 2+ channel blocker,n ifedipine, but blocked by the an analogue of nifedipine, known as AN 1043. 23 Contractile activity was found to increase the activity of these leak channels in dystrophic muscle while leupeptin, an inhibitor of the protease calpain, could prevent the influx of Ca 2+ through these channels. 24 Based on these findings, it was hypothesized that previous contractile activity leads to transient membrane tears and localized influxes of Ca 2+ , which initiates the insertion of leak channels into the membrane, via an exocytotic pathway.T he elevated Ca 2+ also activates proteases, such as calpain, which are required to activate the leak channels. Opening of the leak channels leads to a persistent influx of Ca 2+ and a self-perpetuating damage pathway then operates. 25 At about the same time as the discovery of the Ca 2+ leak channel in dystrophic muscle, the presence of a mechanosensitive cation channel was reported, 11 which had ag reater open probability in mdx muscle fibres when the membrane was stretched by suction from a patch pipette. Importantly,t he increase in activity of these mechanosensitive channels was evident from muscle fibres of young mdx mice, before anysigns of muscle damage and necrosis, 26 suggesting it could be a primary source of Ca 2+ entry in dystrophic muscle. In addition, the occurrence of these channels was also greater in mdx fibres, suggesting there might be an increased density of these channels in the membrane. 27, 28 Recent research carried out in our laboratory has focused on the role of these mechanosensitive ors tretch-activated channels (SACs) in dystrophic muscle damage. In single muscle fibres from mdx mice, it has been found that a significant component of the force reduction and the rise of intracellular Na + caused by a series of stretched (eccentric) contractions can be prevented by twok nown SACb lockers, gadolinium and streptomycin. 29 In a more recent series of experiments, 30 it wasf ound that the rise in [Ca 2+ ] i following stretched contractions of mdx fibres could also be prevented by gadolinium, streptomycin and a news pider venom GsMTx4, the most potent and specific inhibitor of SACs yet identified. 31 This study also showed a significant reduction in muscle damage, assessed histologically,i n mdx mice givens treptomycin orally overt wo weeks. In as eries of experiments currently in progress (Whitehead, Streamer & Allen, unpublished observations) we have found that following stretched contractions of intact mdx muscles, the uptakei nto muscle fibres of a membrane-impermeable fluorescent dye, procion orange, was relatively small immediately after the contractions but increased gradually overt he following hour or so. Moreover, the number of fibres containing procion orange was greatly reduced when muscles were bathed in streptomycin or GsMTx4 prior to and after the stretched contractions. Takent ogether,t hese findings support the hypothesis that the primary source of Ca 2+ entry in dystrophic muscle is through SACs and not via transient mechanical tears, and that the influx of Ca 2+ though these channels contributes to the increased membrane permeability following stretched contractions of mdx muscle. Of course, once the membrane becomes permeable, more Ca 2+ can then enter the fibre and potentially activate the Ca 2+ leak channel, as discussed earlier,thereby providing an additional route for Ca 2+ entry. In a recent clinical trial, the antiobiotic gentamicin, which, likes treptomycin, also blocks SACs, was administered to DMD patients to suppress nonsense mutations in the dystrophin gene. 32 Interestingly,w hile there was no detectable dystrophin expression following 2 weeks of treatment, all 4 patients showed a reduction in serum CK levels. The authors speculated that this result wasd ue to altered activity levels during the trial, however an alternate hypothesis is that gentamicin blocked SACs and reduced CK release from muscles, as outlined earlier.
In a recent paper,e xperimental findings suggested that the canonical transient receptor potential channel 1 (TRPC1) forms the stretch-activated cation channel in vertebrate cells. 33 This discovery opens up the possibility of utilising more molecular-based techniques to identify these channels and to investigate their function in dystrophic muscles. Interestingly,t here is already some evidence that TRPC1, 4 and 6 are present in the sarcolemma of skeletal muscle fibres and that repression of TRPC1 and 4 in mdx muscle, using antisense oligonucleotides, greatly diminished the activity of Ca 2+ channels, which had electrophysiological properties consistent with both store-operated channels and SACs. 28 There are a number of independent experimental findings, which might explain whyS ACs( TRPC1) are overexpressed in mdx muscle and whyt hese channels are more prone to opening during stretch. Firstly,c av eolin-3, the main protein component of caveolae in skeletal muscle, is known to be overexpressed in mdx mice and displays an irregular membrane distribution. 34 Since caveolin-1, which has a similar overall structure to caveolin-3, 35 is known to bind TRPC1 in smooth muscle cells 36 this could mean that by having increased caveolin-3 expression in dystrophic muscle, TRPC1 expression might also be greater.I nf act, there is a suggestion from Western blots that TRPC1 levels are increased in mdx muscle compared to wild-type, 28 although this point was not specifically raised by the authors of this paper.F urthermore, recent work from our laboratory has shown that TRPC1 levels are greater in cardiac muscle from old mdx mice compared to wild-type (Williams & Allen, unpublished observations). In relation to this idea, it has recently been shown in endothelial cells that TRPC1 expression can be increased by the proinflammatory cytokine, tumour necrosis factor (TNFα), 37 which is intriguing in light of the fact that the levels of TNFα are enhanced in mdx muscle. 38 Afi nal point of interest is that caveolin-3 interacts with β-dystroglycan, to which dystrophin normally binds, and is thought to compete with dystrophin for this binding site. 39 Therefore, the interactions between dystrophin, its associated membranebound glycoprotein complex, and caveolin-3, are likely to be critically important in the expression and function of ion channels, such as TRPC1.
Calcium and muscle damage in dystrophic muscle
Proteases
It has been postulated for manyy ears that calcium-activated proteases are involved in protein degradation and subsequent necrosis of dystrophic muscle. 40 Particular attention has been giventothe calciumactivated cysteine protease, calpain, which is known to degrade a wide range of skeletal muscle proteins, including some cytoskeletal and membrane proteins. 41, 42 Calpain activity has been shown to be greater in muscles from mdx mice than wild-type mice 43 and it has been reported that the increased calpain activity in mdx mice occurs during periods of both muscle degeneration and regeneration. 44 When the calpain inhibitor,l eupeptin, wasi njected intramuscularly for 30 days, muscle degeneration and necrosis was reduced in mdx muscles by up to 50%. 45 Using a different experimental approach, 46 an mdx transgenic mouse was developed to overexpress calpastatin, an endogenous calpain inhibitor.I tw as found that the calpastatin transgenic mice had fewer necrotic muscle fibres and had less regenerated fibres, indicating a reduction in accumulated muscle damage, however membrane permeability was unaffected.
Reactive Oxygen Species (ROS)
ROSh av e been proposed, overm anyy ears, as possible mediators of dystrophic muscle damage. Much of the work on the effects of ROS on mdx muscle has been carried out by Rando and colleagues. This group has provided evidence that mdx muscle is more susceptible to ROS-induced damage 47 and that the increased production of ROSc auses lipid peroxidation in the period preceding any necrosis in mdx mice. 48 This finding suggests that ROS might be involved as a primary rather than secondary cause of degeneration. This hypothesis is supported by two in vivo studies, which showed signs of reduced muscle damage in mdx mice givena ntioxidants derivedf rom green tea 49 or fed a lowiron diet, which reduces the production of hydroxyl radicals. 50 Although previous clinical trials have shown no significant therapeutic effect of certain antioxidants on DMD muscles, 51, 52 these studies were carried out on some patients already undergoing muscle degeneration, which may have limited their effectiveness. Also, depending on the type(s) of ROS produced by dystrophic muscles, some antioxidants may be more effective than others in preventing oxidative damage.
An important question is to elucidate the cause(s) of the increased ROS production in dystrophic muscle. It is known that abnormal uptakeo fC a 2+ by mitochondria can result in greater production of ROS. 53, 54 This is a likely source of ROS in dystrophic muscle givent hat mitochondrial oxidative phosphorylation was shown to be impaired in mdx mice, and this was postulated to be due to mitochondrial Ca 2+ overload. 55 This idea is also strengthened by experiments showing that an elevated intracellular Ca 2+ in normal skeletal muscle leads to increased membrane permeability,w hich could be most effectively prevented by deferoxamine, an iron chelator that stops the production of the highly reactive hydroxyl radicals. 56 This study also showed that blocking calciumdependent phospholipase A2 (PLA 2 )a ctivation also prevented some of the increased membrane permeability. Interestingly,P LA 2 activity in muscles from DMD patients has been shown to be significantly greater than that measured in normal muscles. 57 PLA 2 might partially work in conjunction with ROS in causing increased membrane permeability in dystrophic muscle, since there is some evidence that PLA 2 is very effective atr emoving oxidized fatty acids from isolated lipososmes. 58 ROShav e also been implicated in the passive stretchinduced activation of the transcription factor,N F-κB, in mdx muscle, since NF-κBa ctivation could be prevented by the antioxidant NAC. 38 The role of NF-κBi nd ystrophic muscle damage will be discussed in the next section. Interestingly,t he SACb locker,g adolinium, was not very effective atpreventing the activation of NF-κB, 38 although a recent study suggests that both Ca 2+ entry through SACs and increased ROS production contribute to NF-κB activation following stretch of fibroblast cells. 59 Nevertheless, this raises the possibility that there is also a Ca 2+ -independent production of ROS in mdx muscle, which is enhanced during passive stretch of the muscle. One possibility might be NADPH-oxidase, which is known to rapidly produce ROS, within one minute, during cyclic stretch of smooth muscle cells. 60 It has been recently reported that in skeletal muscle, the NADPH-oxidase subunits are located in close proximity to the sarcolemma of muscle fibres. 61 Thus, it is tempting to speculate that if this enzyme complexi ss omehowr egulated by dystrophin, its associated membrane proteins, or other cytoskeletal structures, then its function may be altered in dystrophic muscle, and ROS production could be increased, particularly during stretch. This possibility awaits further experimental findings.
ROSand inflammatory damage ofdystrophic muscle.
As mentioned earlier,t he finding that ROS increases the activation of the NF-κBpathway 38 is significant because NF-κBisatranscription factor that regulates the expression of pro-inflammatory cytokines, such as TNFα and IL-1β, which, in this study,w ere found to be increased in mdx muscle before the period of muscle fibre necrosis. Since TNFα can also stimulate the production of mitochondrial ROS, 62 this could create a positive feedback loop whereby the increased ROS cause further activation of NF-κBa s well as having their own deleterious effects on the muscle. 38 This idea is supported by a recent paper which reported that mdx mice injected with an anti-TNFα antibody,R emicade, displayed less muscle necrosis and reduced inflammatory cell infiltration than control mdx mice. 63 Inflammatory cells such as neutrophils and macrophages can also produce ROS, and it is thought that nitric oxide (NO) can scavenge ROSp roduced by imflammatory cells. 64 In mdx muscle nNOS is downregulated leading to a reduction in NO levels and therefore creating a situation where damage caused by ROSm ay be greater.T he significance of the reduced NO levels in dystrophic muscle is highlighted by a study in which the upregulation of NO in muscles of mdx mice, by using a NOS transgene, resulted in significant reductions in muscle damage, infiltrating inflammatory cells and plasma CK levels. 65 
Conclusion
It has been postulated for manyy ears that a loss of Ca 2+ homeostasis is a significant factor in dystrophic muscle degeneration. This reviewp rovides some new experimental evidence that the primary route of Ca 2+ entry in mdx muscle occurs via ion channels, particularly SACs, rather than through transient mechanical membrane tears. It is proposed that one important consequence of the increased [Ca 2+ ] i is an enhanced production of ROS, which can cause muscle damage through direct effects on muscle fibre proteins and the membrane, as well as through the activation of inflammatory pathways. This is outlined schematically in Fig 1. While this reviewh as focused mainly on the role of Ca 2+ and ROS in dystrophic muscle degeneration, it is clear that there are likely be other physiological pathways, which also contribute to the damage process. Therefore, it is important that any proposed pharmacological treatments for DMD need to account for the multifactorial nature of this degenerative muscle disease. 
